EDT Matinas BioPharma (MTNB) files to sell 16.9M shares of common stock for holdersStay Ahead of the Market: Discover outperforming ...

1 Day MTNB 0.00% DJIA -0.38% Russell 2K 0.11% Health Care/Life Sciences 0.16% ...

Matinas BioPharma's gross profit margin for fiscal years ending December 2019 to 2023 averaged -13,422.8%. Matinas BioPharma's operated at median gross profit margin of -8,968.8% from fiscal years ...

Matinas BioPharma Holdings, Inc.'s Revenue of 0 K ranks in the 0.0% percentile for the Sector. The following table provides additional summary stats: ...

We've identified the following companies as similar to Matinas BioPharma Holdings, Inc. because they operate in a related industry or sector. We also considered size, growth, and various financial ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Scott Lyman, CEO of Belhaven Biopharma, expressed enthusiasm about the results, stating, "The successful outcomes of this dose confirmation and allergic rhinitis study clears the way for our pivotal ...

BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and ...

Shares of Avicanna Inc. AVCN AVCNF rallied more than 26% on the TSX exchange on Monday following the company's release of its full-year 2024 audited financial results. The cannabis-biotech firm ...

The Cattaraugus County Youth Bureau announces this week’s featured Youth Citizenship Award recipient is Jillian Gernatt, the daughter of Nicholas and ...

It’s a biotech en­vi­ron­ment with­out many good choic­es. Even be­fore Pres­i­dent Don­ald Trump’s tar­iff an­nounce­ment pushed stock in­dices to­ward a bear mar­ket, biotech ...